Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.
about
New developments in the clinical use of drug-coated balloon catheters in peripheral arterial diseaseSupera self-expanding stents for endovascular treatment of femoropopliteal disease: a review of the clinical evidenceCritical evaluation of stents in the peripheral arterial disease of the superficial femoral artery - focus on the paclitaxel eluting stentOutcomes following treatment of femoropopliteal in-stent restenosis: a single center experience.Efficacy of two different self-expanding nitinol stents for atherosclerotic femoropopliteal arterial disease (SENS-FP trial): study protocol for a randomized controlled trial.12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis.A budget impact model for paclitaxel-eluting stent in femoropopliteal disease in FranceDurable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized TrialEconomic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK.A single stent strategy in patients with lifestyle limiting claudication: 3-year results from the Durability II trial.Endovascular techniques in limb salvage: stents.Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies.A review of surgically treated patients with obstruction after stenting in the femoropopliteal artery region.Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany.Recent advances in self-expanding stents for use in the superficial femoral and popliteal arteries.Role of the latest endovascular technology in the treatment of intermittent claudication.Drug-coated balloons: how should we incorporate into our practice in treating superficial femoral artery lesions?Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.Use of a New Hybrid Heparin-Bonded Nitinol Ring Stent in the Popliteal Artery: Procedural and Mid-term Clinical and Anatomical Outcomes.Drug-coated balloon treatment for lower extremity vascular disease intervention: an international positioning document.Angiographic Dissection Patterns and Patency Outcomes After Balloon Angioplasty for Superficial Femoral Artery Disease.Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.Feasibility and 1-Year outcomes of subintimal revascularization with supera® stenting of long femoropopliteal occlusions in critical limb ischemia: The "Supersub" Study.Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee.Evaluation of the 4-French Pulsar-18 Self-expanding Nitinol Stent in Long Femoropopliteal Lesions.Factors Affecting the Results of Superficial Femoral Artery Stenting.Nitinol stent implantation for femoropopliteal disease in patients on hemodialysis: results of the 3-year retrospective multicenter APOLLON study.[Stent-assisted recanalization of femoropopliteal arterial occlusive disease. Influence of stent design on patency rates].Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.Investigating the feasibility of using a grit blasting process to coat nitinol stents with hydroxyapatite.Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery.Endovascular therapy by CO2 angiography to prevent contrast-induced nephropathy in patients with chronic kidney disease: a prospective multicenter trial of CO2 angiography registry.Long-term outcomes of SMART stent implantation in patients with femoro-popliteal disease.Endovascular first strategy for de novo TransAtlantic Inter-Society Consensus C and D femoro-popliteal disease: mid-term outcomes from a single tertiary referral center.Comparison of drug-eluting balloon angioplasty with self-expanding interwoven nitinol stent deployment in patients with complex femoropopliteal lesions.Treatment of infrapopliteal post-PTA dissection with tack implants: 12-month results from the TOBA-BTK study.Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: the VIASTAR trial.Efficacy of treatment of edge stenosis of endografts inserted for superficial femoral artery stenotic disease.Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: Midterm results.
P2860
Q26740218-17EA9BDB-0286-40AD-A33E-C0D0B9D111C3Q26800276-682B2A4D-ADB4-4E57-8760-884C5F791DC1Q33710114-DEE849E9-D14F-4336-B2F2-F618E5562C8EQ33898005-DB97D4FF-2600-46D5-B05E-EA5E7EAA11E2Q34227383-EC180E04-1D21-4271-9D4F-71D94C5F84E8Q35150908-B3FE6790-B5FA-45EB-86D2-4A4B07F6F981Q35679312-9272D6FA-BAAB-454C-8762-B8DDB02FBC11Q36678307-DC01DF60-938D-4BFB-B6AD-E60CE68F8381Q36774583-68C33CF2-5E87-49B8-BA2E-2D9A42EE947FQ36920052-CB3D070A-5B5B-4C91-942F-18D33DF7ABC4Q37257331-B1B73A47-0504-4E3A-8798-A65B213BBC4DQ38117375-8F7D415C-575A-443A-AC4E-A508CD64C5CEQ38133465-25E261D1-18DB-4672-9BD0-B7285DF890F5Q38153045-F0E96F19-054D-4D56-BC9C-68571724DBE8Q38208287-A8D74ACF-8E28-420C-9532-A9235E6A2971Q38211926-59F0423E-56BC-46EF-9C3D-E4118D467F3EQ38229004-BD506561-0057-442C-BFE1-F1F81BBBD881Q38386381-EE372182-14A4-44F4-AB8F-A8991EA6E52EQ38392409-2E5DEB91-2F70-417C-BA01-2B9C5032609CQ38473355-CC6042E4-F7AD-4612-9C5C-CD4768A6C7D4Q38502277-917C61B2-C8E6-4639-BB6A-D4ECD99F6359Q38870718-42D1E983-DF25-4049-AD61-A341B9A95BB6Q38968545-7AE573D6-3010-4BA9-960D-D59665AA04D2Q39174616-BF59718C-28C8-43A0-A898-F00C6D28DFF9Q39435685-4E9D1102-2A8D-412C-894C-99C9F3607B8AQ39574216-24900CC8-0B14-4E4C-AFE1-DA2B0D54755CQ40302026-7C120F60-62F1-49EA-B4C2-DCF03131BB02Q40576612-9E8CAAFF-3964-44C3-9644-43594284053EQ40932289-977ED468-A2B3-4CE1-89D2-2887D1E46C92Q41965693-CE072EC7-1227-4554-8835-4DC49E40C86EQ43941133-118A77AA-457A-40D3-BB6D-A433033BA3E6Q44454294-DCD8D62D-014B-4809-B260-9F0E2C42BE24Q51036742-4F741300-AD82-4F1B-A3D4-1205EAF7FD51Q51195575-04BB10BA-6A6A-42F0-8475-07E27FB5ACA6Q51744227-0598BC66-CD25-4E65-8683-63DC0FC35237Q52576939-660A0EC1-5B9E-4426-97C3-0CF424A00699Q52638663-18312134-61BE-4C9E-BD52-EC6AE4C8C520Q53036848-E013CD87-DB93-4B71-B1C8-DFE73FBD1F50Q53200219-1A7DF6D1-42C4-4C11-9FF8-95E6201CFCE2Q53311664-83774D7B-F846-40E2-99C6-8690EE8DA378
P2860
Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@en
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@nl
type
label
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@en
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@nl
prefLabel
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@en
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@nl
P2093
P356
P1476
Nitinol stent implantation in ...... lts of the DURABILITY I study.
@en
P2093
Dierk Scheinert
Frank Vermassen
Giovanni Torsello
Hans-Martin Gissler
Herman Schroë
Johannes Lammer
Johannes Ruef
Kim Daenens
Klaus Mathias
Marc Bosiers
P304
P356
10.1583/08-2676.1
P577
2009-06-01T00:00:00Z